Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bacchus gets US nod for thrombus drug delivery:

This article was originally published in Clinica

Executive Summary

Bacchus Vascular has gained FDA 510(k) clearance to sell in the US its Trellis infusion system, which facilitates the delivery of drugs, including thrombolytic agents, into the peripheral vasculature. The catheter-based drug delivery system, which was cleared for sale in Europe earlier this month (see Clinica, No 996, p 20), allows doctors to treat difficult areas of vascular occlusion and promises safety advantages, time savings and improved outcomes in thrombus management, says the Santa Clara, California firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064920

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel